OTC · AOBI
American Oriental Bioengineering, Inc.
$0.01$0.00 (0.0%)
American Oriental Bioengineering, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · NRTSF · USD
Stock price, earnings
Quote as of Oct 23, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Nobilis Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nobilis Health Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nobilis Health Corp. focuses on the development and operation of ambulatory surgical centers, providing cutting-edge surgical solutions. The company owns and manages a diverse range of facilities, including both outpatient and acute care settings. Its business operations are divided into two primary segments: Medical Services and Marketing Services. The Medical Services division is responsible for the management of hospitals, outpatient clinics, and various other healthcare offerings. Complementing this, the Marketing Services segment delivers promotional strategies, patient educational programs, and comprehensive patient care coordination. Nobilis Health Corp. was established on March 16, 2007, and its corporate headquarters are located in Houston, TX.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Nov 7, 2016 |
| -$0.04-157.14% vs estimate |
| $70.68M |
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
American Oriental Bioengineering, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cannabiz Mobile, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.02% below the high.
$0.00$0.00 (0.0%)
Enchanted World Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Coenzyme-A Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cardax, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Acusphere, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Mymetics Corporation’s quoted price sits in the lower half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Aspyra Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
